Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak, Sri Lekha Tummalapalli, L. Ebony Boulware, et al.
Kidney International (2020) Vol. 99, Iss. 1, pp. 34-47
Open Access | Times Cited: 369

Showing 1-25 of 369 citing articles:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1997
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Ian H. de Boer, Kamlesh Khunti, Tami Sadusky, et al.
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 3075-3090
Open Access | Times Cited: 417
Chronic kidney disease and the global public health agenda: an international consensus
Anna Francis, Meera N. Harhay, Albert Ong, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 473-485
Open Access | Times Cited: 269
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Ian H. de Boer, Kamlesh Khunti, Tami Sadusky, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. 974-989
Open Access | Times Cited: 171
Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
Andrew S. Levey, Morgan E. Grams, Lesley A. Inker
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2120-2128
Closed Access | Times Cited: 99
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study
Navdeep Tangri, Kiyoshi Mori, Markus P. Schneider, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e067386-e067386
Open Access | Times Cited: 63
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Dan‐Qin Sun, Giovanni Targher, Christopher D. Byrne, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 3, pp. 386-403
Open Access | Times Cited: 59
Population-Wide Screening for Chronic Kidney Disease
Marika Cusick, Rebecca L. Tisdale, Glenn M. Chertow, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 6, pp. 788-797
Closed Access | Times Cited: 55
Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease
Chi D. Chu, Fang Xia, Yuxian Du, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2326230-e2326230
Open Access | Times Cited: 54
Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019
Junjie Hu, Runjiang Ke, Wilhem Teixeira, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 1, pp. 60-71
Open Access | Times Cited: 51
Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kai‐Uwe Eckardt, Cynthia Delgado, Hiddo J.L. Heerspink, et al.
Kidney International (2023) Vol. 104, Iss. 5, pp. 888-903
Open Access | Times Cited: 45
Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?
Douglas R. Farrell, Joseph A. Vassalotti
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 18
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
Are your kidneys Ok? Detect early to protect kidney health
Joseph A. Vassalotti, Anna Francis, Augusto César Soares dos Santos, et al.
Kidney International (2025) Vol. 107, Iss. 3, pp. 370-377
Closed Access | Times Cited: 2
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial
Ofri Mosenzon, Itamar Raz, Stephen D. Wiviott, et al.
Diabetes Care (2022) Vol. 45, Iss. 10, pp. 2350-2359
Open Access | Times Cited: 51
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study
Shengnan Chen, Lei Chen, Hongli Jiang
Renal Failure (2022) Vol. 44, Iss. 1, pp. 1310-1319
Open Access | Times Cited: 42
Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study
Dominique van Mil, Lyanne M. Kieneker, Birgitte Evers-Roeten, et al.
The Lancet (2023) Vol. 402, Iss. 10407, pp. 1052-1064
Open Access | Times Cited: 35
Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review
See Cheng Yeo, Hankun Wang, Gary Ang, et al.
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Advances in the management of chronic kidney disease
Teresa K. Chen, Melanie P. Hoenig, Dorothea Nitsch, et al.
BMJ (2023), pp. e074216-e074216
Open Access | Times Cited: 29
Discrepancies between Cystatin C–Based and Creatinine-Based eGFR
Danielle K. Farrington, Aditya Surapaneni, Kunihiro Matsushita, et al.
Clinical Journal of the American Society of Nephrology (2023)
Open Access | Times Cited: 28
Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment
Marion Pépin, Aleksandra Klimkowicz‐Mrowiec, Olivier Godefroy, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 9, pp. 2899-2911
Open Access | Times Cited: 27
Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study
Navdeep Tangri, Emily Peach, Stefan Franzén, et al.
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2869-2885
Open Access | Times Cited: 24
A deep learning model for novel systemic biomarkers in photographs of the external eye: a retrospective study
Boris Babenko, Ilana Traynis, Christina Chen, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 5, pp. e257-e264
Open Access | Times Cited: 23
Projecting the economic burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
Steven J. Chadban, Mustafa Arıcı, Albert Power, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102615-102615
Open Access | Times Cited: 16
Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study
Gaetano Santulli, Valeria Visco, Michele Ciccarelli, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top